← Browse by Condition
Medical Condition
circulating tumor dna
Total Trials
2
Recruiting Now
2
Trial Phases
Various
NCT05598528
Recruiting
Exploring the Mechanism of Primary Resistance to Third-generation EGFR-TKIs as First-line Treatment in EGFR-positive Advanced NSCLC (PRECISE Study)
Enrollment
210 pts
Location
China
Sponsor
Second Xiangya Hospital of Cen...
NCT06707519
Recruiting
NSCLC Liquid Biopsies and Exhaled VOC
Enrollment
210 pts
Location
Canada
Sponsor
St. Joseph's Healthcare Hamilt...